Indeed, dimethyl fumarate, an immunomodulatory drug used to treat psoriasis and multiple sclerosis, was recently shown to mediate anti-inflammatory effects through inactivating the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in activated myeloid and lymphoid cells [48]. This evidence concerns the gene GAPDH and psoriasis.